Dental Care Clinics in Tobyhanna, PA Accepting Medicare
2 Dental Care Clinics found. Showing 1 - 2
 Dr. Tajul Islam Dds Pc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 300 Community Dr, Suite C-2, Tobyhanna, PA 18466 Phone: 718-974-4775 |
Apple Dental Care, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 100 Community Dr, Suite 201, Tobyhanna, PA 18466 Phone: 570-839-6969 Fax: 570-839-8788 |
News Archive
Residency cap may hamper efforts to expand number of doctors
Bloomberg examines the need for more primary care physicians and the limit on the number of slots for training doctors.
UC review finds rate of rtPA treatment for ischemic stroke in the U.S. doubled since 2005
In a review of nationwide hospital databases, University of Cincinnati (UC) emergency medicine and neurology researchers have found that the rate of treatment with the standard therapy for acute ischemic stroke patients has doubled since 2005.
Olympus enhances its life science imaging and analysis software cellSens
Focusing on ease of use for routine applications, the latest cellSens software release, version 1.8, offers flexible and user-centric imaging, processing, analysing and reporting. New and enhanced functions include a fully customisable user interface, precise frame-by-frame sample navigation and easy one-button switching between wells.
Zoledronic acid increases disease-free survival in premenopausal women with HR+ early breast cancer
Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival compared to tamoxifen in premenopausal women with hormone receptor positive (HR+) early breast cancer, according to results reported at ESMO 2018 Congress in Munich.
Cyclacel announces completion of private placement sale
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
› Verified 8 days ago